company background image
4183 logo

EPS Bio Technology TPEX:4183 Stock Report

Last Price

NT$22.45

Market Cap

NT$534.3m

7D

10.0%

1Y

15.1%

Updated

14 Apr, 2024

Data

Company Financials

EPS Bio Technology Corp.

TPEX:4183 Stock Report

Market Cap: NT$534.3m

4183 Stock Overview

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan.

4183 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends3/6

EPS Bio Technology Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EPS Bio Technology
Historical stock prices
Current Share PriceNT$22.45
52 Week HighNT$30.00
52 Week LowNT$19.15
Beta0.60
1 Month Change6.90%
3 Month Change-2.39%
1 Year Change15.13%
3 Year Change-1.54%
5 Year Change21.68%
Change since IPO31.91%

Recent News & Updates

Recent updates

Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)

Apr 16
Should You Or Shouldn't You: A Dividend Analysis on EPS Bio Technology Corp. (GTSM:4183)

Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?

Mar 20
Will EPS Bio Technology (GTSM:4183) Multiply In Value Going Forward?

Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative

Feb 22
Here's Why We Think EPS Bio Technology's (GTSM:4183) Statutory Earnings Might Be Conservative

Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?

Feb 01
Do Fundamentals Have Any Role To Play In Driving EPS Bio Technology Corp.'s (GTSM:4183) Stock Up Recently?

Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?

Jan 04
Should EPS Bio Technology Corp. (GTSM:4183) Be Part Of Your Dividend Portfolio?

Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?

Dec 14
Is EPS Bio Technology (GTSM:4183) Likely To Turn Things Around?

We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential

Nov 23
We Think EPS Bio Technology's (GTSM:4183) Statutory Profit Might Understate Its Earnings Potential

Shareholder Returns

4183TW Medical EquipmentTW Market
7D10.0%-0.3%1.8%
1Y15.1%4.3%28.5%

Return vs Industry: 4183 exceeded the TW Medical Equipment industry which returned 4.3% over the past year.

Return vs Market: 4183 underperformed the TW Market which returned 28.5% over the past year.

Price Volatility

Is 4183's price volatile compared to industry and market?
4183 volatility
4183 Average Weekly Movement6.0%
Medical Equipment Industry Average Movement4.4%
Market Average Movement4.4%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.0%

Stable Share Price: 4183 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4183's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006116n/awww.epsbio.com

EPS Bio Technology Corp. manufactures and sells OEM/ODM blood glucose system in Taiwan. It also provides test strip; diabetic self-monitoring blood glucose systems under the EASYMAX and MDT2 BLE name; and wearable, and NFC and Bluetooth connectivity blood glucose monitors. The company was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

EPS Bio Technology Corp. Fundamentals Summary

How do EPS Bio Technology's earnings and revenue compare to its market cap?
4183 fundamental statistics
Market capNT$534.31m
Earnings (TTM)NT$20.99m
Revenue (TTM)NT$470.17m

25.5x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4183 income statement (TTM)
RevenueNT$470.17m
Cost of RevenueNT$354.46m
Gross ProfitNT$115.71m
Other ExpensesNT$94.72m
EarningsNT$20.99m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.88
Gross Margin24.61%
Net Profit Margin4.46%
Debt/Equity Ratio5.1%

How did 4183 perform over the long term?

See historical performance and comparison

Dividends

4.4%

Current Dividend Yield

119%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.